# Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)

> **NCT02093273** · PHASE2 · COMPLETED · sponsor: **PT Bio Farma** · enrollment: 240 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** tOPV pilot batch
- **BIOLOGICAL:** tOPV commercial batch

## Key facts

- **NCT ID:** NCT02093273
- **Lead sponsor:** PT Bio Farma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2014-01
- **Final completion:** 2014-02
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2014-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02093273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02093273, "Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02093273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*